Loading clinical trials...
Loading clinical trials...
To investigate the efficacy and safety of Qishenyiqi in patients with microvascular angina pectoris. Long-term follow-up of 1 year will be performed to evaluate the effect of Qishenyiqi on coronary fl...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Qilu Hospital of Shandong University
NCT06991322 · Coronary Microvascular Dysfunction, Coronary Microvascular Disease
NCT05743140 · Coronary Microvascular Disease
NCT06125392 · Coronary Microvascular Disease, Coronary Vasospasm
NCT06597851 · Coronary Microvascular Dysfunction, Coronary Microvascular Disease, and more
NCT05178914 · Coronary Microvascular Disease
Qianfoshan Hospital, Shandong University
Jinan, Shandong
Qilu Hospital of Shandong University
Jinan, Shandong
Jinan Central Hospital Affiliated to Shandong First Medical University
Jinan, Shandong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions